CROSSJECT (EPA:ALCJ) | WebDisclosure

BRIEF

published on 06/12/2024 at 07:35, 6 months 9 days ago

Crossject nomme Dan Chiche, MD au poste de Directeur Médical Amérique du Nord

Crossject ZEPIZURE® Dan Chiche Directeur Médical
PRESS RELEASE

published on 06/12/2024 at 07:30, 6 months 9 days ago

Crossject appoints Dan Chiche, MD as Chief Medical Officer North America
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America, strengthening leadership team and expanding presence in U.S. Supports ZEPIZURE® regulatory milestones targeting in 2025

North America Chief Medical Officer Crossject ZEPIZURE Dan Chiche
PRESS RELEASE

published on 06/12/2024 at 07:30, 6 months 9 days ago

Crossject nomme Dan Chiche, MD au poste de Directeur Médical Amérique du Nord
Nomination de Dan Chiche, MD en tant que Directeur Médical Amérique du Nord chez Crossject, renforçant l'équipe dirigeante et la présence aux États-Unis pour lancer ZEPIZURE en 2025

Amérique Du Nord Crossject ZEPIZURE Dan Chiche Directeur Médical
BRIEF

published on 06/04/2024 at 19:35, 6 months 17 days ago

Crossject annonce la clôture réussie d'une offre de droits de 8 millions d'euros

Approbation De La FDA Offre De Droits ZEPIZURE® Projet Croisé Traitement De L'épilepsie
BRIEF

published on 06/04/2024 at 19:35, 6 months 17 days ago

Crossject Announces Successful Closing of €8 Million Rights Offering

FDA Approval Rights Offering Crossject ZEPIZURE® Epilepsy Treatment
PRESS RELEASE

published on 06/04/2024 at 19:30, 6 months 17 days ago

Crossject annonce le vif succès de son augmentation de capital de 8 millions d’euros
Crossject annonce le vif succès de son augmentation de capital de 8 millions d'euros pour le développement de ZEPIZURE®. Opération avec maintien du droit préférentiel de souscription et soutien de Gemmes Venture

FDA Augmentation De Capital Crossject ZEPIZURE Gemmes Venture
PRESS RELEASE

published on 06/04/2024 at 19:30, 6 months 17 days ago

Crossject announces highly successful closing of its €8 million rights offering
Crossject successfully closes €8 million rights offering, securing funding for ZEPIZURE® development and FDA approval. Gemmes Venture remains a key supporter

FDA Approval Rights Offering Crossject ZEPIZURE® Gemmes Venture
BRIEF

published on 05/30/2024 at 10:35, 6 months 22 days ago

Crossject: Publication of Clinical Data on ZEPIZURE®

Crossject ZEPIZURE® Neurology And Therapy Midazolam Needle-free Injection
BRIEF

published on 05/30/2024 at 10:35, 6 months 22 days ago

Crossject : Publication de Données Cliniques sur ZEPIZURE®

Crossject ZEPIZURE® Neurology And Therapy Midazolam Injection Sans Aiguille
PRESS RELEASE

published on 05/30/2024 at 10:30, 6 months 22 days ago

Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy
Crossject announces publication of clinical data on ZEPIZURE in Neurology and Therapy, highlighting bioequivalence versus Dormicum, early onset, and low variability

Clinical Data Crossject Neurology And Therapy ZEPIZURE Needle-free Auto-injector

Published on 12/21/2024 at 01:30, 1 day 4 hours ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 1 day 4 hours ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 1 day 5 hours ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 1 day 6 hours ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 1 day 6 hours ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 1 day 5 hours ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 1 day 5 hours ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day 10 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day 11 hours ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 17 hours 44 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 17 hours 44 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 12 hours ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News